The test delivers results in just 18 minutes on Roche’s cobas analysers, providing a fast and reliable diagnostic method. The test enables earlier identification of patients with significant liver ...
INDIANAPOLIS, Dec. 5, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated ...
The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad access to high quality testing in a timely manner.
Thermo Fisher has extended a deal to get its sepsis test on Roche's Elecsys Cobas platform.--Courtesy of Roche Thermo Fisher ($TMO) and Roche Diagnostics ($RHHBY ...
HERLEV, Denmark, May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT ...
Roche announced the launch of the Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV) infections in countries accepting the CE mark. By testing for ...
(RTTNews) - Roche (RHHBY) announced that its Elecsys beta-Amyloid CSF II and Elecsys Phospho-Tau CSF assays have received FDA 510(k) clearance. The Elecsys AD CSF Abeta42 and pTau181 assays measure ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results